Mycobacterium tuberculosis: Here today, and here tomorrow

Nature Reviews Molecular Cell Biology

Volumn 2, Issue 8, 2001, Pages 569-577

  Russell, David G ^a  

^a Animal Health Diagnostic Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

BCG VACCINE; CALMODULIN; CARRIER PROTEIN; CATION; CATION TRANSPORT PROTEIN; HLA D ANTIGEN; ISOCITRATE LYASE; LIPID; MEMBRANE PROTEIN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; NATURAL RESISTANCE-ASSOCIATED MACROPHAGE PROTEIN 1; PHTHIOCEROL DIMYCOCEROSATE; TRANSFERRIN; TUBERCULOSTATIC AGENT;

ADULT; ANIMAL; ATYPICAL MYCOBACTERIOSIS; BIOLOGICAL MODEL; CELL VACUOLE; CHEMISTRY; CHILD; DRUG DESIGN; ENDOSOME; ENZYMOLOGY; GENETICS; HUMAN; IMMUNOLOGY; INTRACELLULAR MEMBRANE; ION TRANSPORT; LUNG ALVEOLUS MACROPHAGE; LUNG TUBERCULOSIS; LYSOSOME; MEMBRANE FUSION; METABOLISM; MICROBIOLOGY; MOUSE; MOUSE MUTANT; MYCOBACTERIUM AVIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; PATHOLOGY; PH; PHAGOSOME; PHYSIOLOGY; REVIEW; ULTRASTRUCTURE;

ADULT; ANIMALS; ANTITUBERCULAR AGENTS; BCG VACCINE; CALMODULIN; CARRIER PROTEINS; CATION TRANSPORT PROTEINS; CATIONS; CHILD; DRUG DESIGN; ENDOSOMES; HLA-D ANTIGENS; HUMANS; HYDROGEN-ION CONCENTRATION; INTRACELLULAR MEMBRANES; ION TRANSPORT; ISOCITRATE LYASE; LIPIDS; LYSOSOMES; MACROPHAGES, ALVEOLAR; MEMBRANE FUSION; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; MYCOBACTERIUM AVIUM; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; PHAGOSOMES; TRANSFERRIN; TUBERCULOSIS, PULMONARY; VACUOLES;

EID: 0035432383     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/35085034     Document Type: Review

References (70)

1. Cole, S. T. et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537-544 (1998).
2. Zimmerli, S., Edwards, S. & Ernst, J. D. Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages. Am. J. Respir. Cell. Mol. Biol. 15, 760-770 (1996).
3. Brown, C. A., Draper, P. & Hart, P. D. Mycobacteria and lysosomes: a paradox. Nature 221, 658-660 (1969). This is a classic paper that reported the initial observations that Mycobacterium-containing vacuoles failed to fuse with lysosomes.
4. Hart, P. D., Armstrong, J. A., Brown, C. A. & Draper, P. Ultrastructural study of the behavior of macrophages toward parasitic mycobacteria. Infect. Immun. 5, 803-807 (1972).
5. Hart, P. D. & Armstrong, J. A. Strain virulence and the lysosomal response in macrophages infected with Mycobacterium tuberculosis. Infect. Immun. 10, 742-746 (1974).
6. Armstrong, J. A. & Hart, P. D. Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. J. Exp. Med. 142, 1-16 (1975).
7. Crowle, A. J., Dahl, R., Ross, E. & May, M. H. Evidence that vesicles containing living, virulent Mycobacterium tuberculosis or Mycobacterium avium in cultured human macrophages are not acidic. Infect. Immun. 59, 1823-1831 (1991).
8. Sturgill-Koszycki, S. et al. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 263, 678-681 (1994). This paper marked the transition from descriptive to experimental, biochemical analysis of the Mycobacterium-containing vacuole and provided an initial explanation as to why these vacuoles failed to acidify.
9. Frehel, C., de Chastellier, C., Lang, T. & Rastogi, N. Evidence for inhibition of fusion of lysosomal and prelysosomal compartments with phagosomes in macrophages infected with pathogenic Mycobacterium avium. Infect. Immun. 52, 252-262 (1986).
10. Clemens, D. L. & Horwitz, M. A. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J. Exp. Med. 181, 257-270 (1995).
11. Clemens, D. L. & Horwitz, M. A. The Mycobacterium tuberculosis phagosome interacts with early endosomes and is accessible to exogenously administered fransferrin. J. Exp. Med. 184, 1349-1355 (1996). This paper, together with reference 13, showed that the Mycobacterium-containing vacuole was arrested within the transferrin recycling pathway of the host macrophage.
12. Russell, D. G., Dant, J. & Sturgill-Koszycki, S. Mycobacterium avium-and Mycobacterium tuberculosis-containing vacuoles are dynamic, fusion-competent vesicles that are accessible to glycosphingolipids from the host cell plasmalemma. J. Immunol. 156, 4764-4773 (1996).
13. Sturgill-Koszycki, S., Schaible, U. E. & Russell, D. G. Mycobacterium-containing phagosomes are accessible to early endosomes and reflect a transitional state in normal phagosome biogenesis. EMBO J. 15, 6960-6968 (1996). This paper provided a fuller understanding that the Mycobacterium-containing vacuole showed limited acidification because it was arrested within the eariy endosomal network and remained accessible to transferrin.
14. Ullrich, H. J., Beatty, W. L. & Russell, D. G. Direct delivery of procathepsin D to phagosomes: implications for phagosome biogenesis and parasitism by Mycobacterium. Eur. J. Cell Biol. 78, 739-748 (1999).
15. Rohrer, J., Schweizer, A., Russell, D. & Kornfeld, S. The targeting of Lamp1 to lysosomes is dependent on the spacing of its cytoplasmic tail tyrosine sorting motif relative to the membrane. J. Cell Biol. 132, 565-576 (1996).
16. Via, L. E. et al. Arrest of mycobacterial phagosome maturation is caused by a block in vesicle fusion between stages controlled by rab5 and rab7. J. Biol. Chem. 272, 13326-13331 (1997). This was the first demonstration of the stable association of the early endosomal GTPase Rab5 with the Mycobacterium-containing vacuole.
17. Clemens, D. L., Lee, B. Y. & Horwitz, M. A. Deviant expression of Rab5 on phagosomes containing the intracellufar pathogens Mycobacterium tuberculosis and Legionella pneumophila is associated with altered phagosomal fate. Infect. Immun. 68, 2671-2684 (2000).
18. Colombo, M. I., Beron, W. & Stahl, P. D. Calmodulin regulates endosome fusion. J. Biol. Chem. 272, 7707-7712 (1997).
19. 2+ signaling by Mycobacterium tuberculosis is associated with reduced phagosome-lysosome fusion and increased survival within human macrophages. J. Exp. Med. 191, 287-302 (2000). An extremely interesting experimental study linking calmodulin and calcium to the transition of the Mycobacterium-containing vacuole from an early endosomal to a lysosomal environment.
20. Malik, Z. A., Iyer, S. S. &. Kusner, D. J. Mycobacterium tuberculosis phagosomes exhibit altered calmodulin-dependent signal transduction: contribution to inhibition of phagosome-lysosome fusion and intracellular survival in human macrophages. J. Immunol. 166, 3392-3401 (2001).
21. Ferrari, G., Langen, H., Naito, M. & Pieters, J. A coat protein on phagosomes involved in the intracellular survival of mycobacteria. Cell 97, 435-447 (1999). An interesting description of the stable association of the early phagosome coat protein coronin 1 (TACO) with the Mycobacterium-containing vacuoles.
22. Maniak, M., Rauchenberger, R., Albrecht, R., Murphy, J. & Gerisch, G. Coronin involved in phagocytosis: dynamics of particle-induced relocalization visualized by a green fluorescent protein tag. Cell 83, 915-924 (1995).
23. Gatfield, J. & Pieters, J. Essential role for cholesterol in entry of mycobacteria into macrophages. Science 288, 1647-1650 (2000).
24. Wooldridge, K. G., Williams, P. H. & Ketley, J. M. Host signal transduction and endocytosis of Campylobacter jejuni. Microb. Pathog. 21, 299-305 (1996).
25. Peyron, P., Bordier, C., N'Diaye, E. N. & Maridonneau-Parini, I. Nonopsonic phagocytosis of Mycobacterium kansasii by human neutrophils depends on cholesterol and is mediated by CR3 associated with glycosylphosphatidylinositol-anchored proteins. J. Immunol. 165, 5186-5191 (2000).
26. Gruenheid, S. & Gros, P. Genetic susceptibility to intracellular infections: Nramp1, macrophage function and divalent cations transport. Curr. Opin. Microbiol. 3, 43-48 (2000).
27. Blackwell, J. M., Searle, S., Goswami, T. & Miller, E. N. Understanding the multiple functions of Nramp1. Microbes Infect. 2, 317-321 (2000).
28. Hackam, D. J. et al. Host resistance to intracellular infection: mutation of natural resistance-associated macrophage protein 1 (Nramp1) impairs phagosomal acidification. J. Exp. Med. 188, 351-364 (1998).
29. -/bivalent cation antiporter. Biochem. J. 354, 511-519 (2001).
30. Jabado, N. et al. Natural resistance to intracellular infections: natural resistance associated macrophage protein 1 (NRAMP1) functions as a pH-dependent manganese transporter at the phagosomal membrane. J. Exp. Med. 191, 1-12 (2000).
31. Gordon, A. H., Hart, P. D. & Young, M. R. Ammonia inhibits phagosome-lysosome fusion in macrophages. Nature 286, 79-80 (1980).
32. Reyrat, J. M., Lopez-Ramirez, G., Ofredo, C., Gicquel, B. & Winter, N. Urease activity does not contribute dramatically to persistence of Mycobacterium bovis bacillus Calmette-Guérin. Infect. Immun. 64, 3934-3936 (1996).
33. de Chastellier, C., Lang, T. & Thilo, L. Phagocytic processing of the macrophage endoparasite, Mycobacterium avium, in comparison to phagosomes which contain Bacillus subtilis or latex beads. Eur. J. Cell Biol. 68, 167-182 (1995).
34. Oh, Y. K. & Swanson, J. A. Different fates of phagocytosed particles after delivery into macrophage lysosomes. J. Cell Biol. 132, 585-593 (1996).
35. Schaible, U. E., Sturgill-Koszycki, S., Schlesinger, P. H. & Russell, D. G. Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. J. Immunol. 160, 1290-1296 (1998).
36. Via, L. E. et al. Effects of cytokines on mycobacterial phagosome maturation. J. Cell Sci. 111, 897-905 (1998).
37. MacMicking, J. D. et al. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl Acad. Sci. USA 94, 5243-5248 (1997).
38. Wei, X. Q. et al. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375, 408-411 (1995).
39. Chan, J., Tanaka, K., Carroll, D., Flynn, J. & Bloom, B. R. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect. Immun. 63, 736-740 (1995).
40. Clemens, D. L. Characterization of the Mycobacterium tuberculosis phagosome. Trends Microbiol. 4, 113-118 (1996).
41. Ullrich, H. J., Beatty, W. L. & Russell, D. G. Interaction of Mycobacterium avium-containing phagosomes with the antigen presentation pathway. J. Immunol. 165, 6073-6080 (2000).
42. + T cells of mycobacteria growing in human macrophages. Science 260, 984-986 (1993).
43. Wadee, A. A., Kuschke, R. H. & Dooms, T. G. The inhibitory effects of Mycobacterium tuberculosis on MHC class II expression by monocytes activated with riminophenazines and phagocyte stimulants. Clin. Exp. Immunol. 100, 434-439 (1995).
44. Wojciechowski, W., DeSanctis, J., Skamene, E. & Radzioch, D. Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis bacillus Calmette-Guérin involves class II transactivator and depends on the Nramp1 gene. J. Immunol. 163, 2688-2696 (1999).
45. Sienger, S., Niazi, K. R. & Modlin, R. L. Down-regulation of CD1 on antigen-presenting cells by infection with Mycobacterium tuberculosis. J. Immunol. 161, 3582-3588 (1998).
46. Noss, E. H., Harding, C. V. & Boom, W. H. Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages. Cell. Immunol. 201, 63-74 (2000).
47. VanHeyningen, T. K., Collins, H. L. & Russell, D. G. IL-6 produced by macrophages infected with Mycobacterium species suppresses T cell responses. J. Immunol. 158, 330-337 (1997).
48. Ting, L. M., Kim, A. C., Cattamanchi, A. & Ernst, J. D. Mycobacterium tuberculosis inhibits IFN-γ transcriptional responses without inhibiting activation of STAT1. J. Immunol. 163, 3898-3906 (1999).
49. Bardarov, S. et al. Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 94, 10961-10966 (1997).
50. Pelicic, V. et al. Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 94, 10955-10960 (1997).
51. Camacho, L. R., Ensergueix, D., Perez, E., Gicquel, B. & Guilhot, C. Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol. Microbiol. 34, 257-267 (1999).
52. Cox, J. S., Chen, B., McNeil, M. & Jacobs, W. R. Jr Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature 402, 79-83 (1999).
53. Beatty, W. B., Rhoades, E. R., Ullrich, H. J., Chatterjee, D. & Russell, D. G. Trafficking and release of mycobacterial lipids from infected macrophages. Traffic 1, 235-247 (2000).
54. Beatty, W. L. & Russell, D. G. Identification of mycobacterial surface proteins released into subcellular compartments of infected macrophages. Infect. Immunol. 68, 6997-7002 (2000).
55. Beatty, W. L., Ullrich, H. J. & Russell, D. G. Mycobacterial surface moieties are released from infected macrophages by a constitutive exocytic event. Eur. J. Cell. Biol. 80, 31-40 (2001).
56. Honer Zu Bentrup, K., Miczak, A., Swenson, D. L. & Russell, D. G. Characterization of activity and expression of isocitrate lyase in Mycobacterium avium and Mycobacterium tuberculosis. J. Bacteriol. 181, 7161-7167 (1999).
57. Wayne, L. G. Dormancy of Mycobacterium tuberculosis and latency of disease. Eur. J. Clin. Microbiol. Infect. Dis. 13, 908-914 (1994).
58. Wayne, L. G. & Hayes, L. G. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect. Immun. 64, 2062-2069 (1996).
59. McKinney, J. D. et al. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406, 735-738 (2000). This is the first demonstration that the changing intracellular environment of an activated, versus a resting, macrophage culminates in a shift in metabolism in the infecting Mycobacterium.
60. Duclos, S. et al. Rab5 regulates the kiss and run fusion between phagosomes and endosomes and the acquisition of phagosome leishmanicidal properties in RAW 264.7 macrophages. J. Cell Sci. 113, 3531-3541 (2000).
61. Hao, M. & Maxfield, F. R. Characterization of rapid membrane internalization and recycling. J. Biol. Chem. 275, 15279-15286 (2000).
62. Schweizer, A., Kornfeld, S. & Rohrer, J. Cysteine34 of the cytoplasmic tail of the cation-dependent mannose 6-phosphate receptor is reversibly palmitoylated and required for normal trafficking and lysosomal enzyme sorting. J. Cell Biol. 132, 577-584 (1996).
63. Fine, P. E. Vaccines, genes and trials. Novartis Found. Symp. 217, 57-69 (1998).
64. Kaufmann, S. H. Is the development of a new tuberculosis vaccine possible? Nature Med. 6, 955-960 (2000).
65. Hirsch, C. S., Johnson, J. L. & Ellner, J. J. Pulmonary tuberculosis. Curr. Opin. Pulm. Med. 5, 143-150 (1999).
66. Maher, D. & Nunn, P. Commentary: making tuberculosis treatment available for all. Bull. World Health Organ. 76, 125-126 (1998).
67. Yew, W. W. Directly observed therapy, short-course: the best way to prevent multidrug-resistant tuberculosis. Chemotherapy 45, 26-33 (1999).
68. Dick, T. Dormant tubercle bacilli: the key to more effective TB chemotherapy? J. Antimicrob. Chemother. 47, 117-118 (2001).
69. McKinney, J. D. In vivo veritas: the search for TB drug targets goes live. Nature Med. 6, 1330-1333 (2000).
70. Barry, C. E., Slayden, R. A., Sampson, A. E. & Lee, R. E. Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs. Biochem. Pharmacol. 59, 221-231 (2000).